50.88 USD
-2.53 (-4.74%)
52.4 USD
+1.52 (+2.99%)
We assign a fundamental rating of 4 out of 10 to BRKR. BRKR was compared to 57 industry peers in the Life Sciences Tools & Services industry. There are concerns on the financial health of BRKR while its profitability can be described as average. BRKR is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- In the past year BRKR was profitable.
- BRKR had a positive operating cash flow in the past year.
- In the past 5 years BRKR has always been profitable.
- BRKR had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- The Return On Assets of BRKR (-0.37%) is better than 64.91% of its industry peers.
- BRKR has a better Return On Equity (-0.97%) than 64.91% of its industry peers.
- BRKR has a better Return On Invested Capital (4.01%) than 68.42% of its industry peers.
- BRKR had an Average Return On Invested Capital over the past 3 years of 9.30%. This is below the industry average of 13.75%.
- The 3 year average ROIC (9.30%) for BRKR is well above the current ROIC(4.01%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.37% | ||
| ROE | -0.97% | ||
| ROIC | 4.01% |
ROA(3y)6.74%
ROA(5y)6.6%
ROE(3y)21.33%
ROE(5y)21.26%
ROIC(3y)9.3%
ROIC(5y)9.28%
1.3 Margins
- In the last couple of years the Profit Margin of BRKR has declined.
- Looking at the Operating Margin, with a value of 8.99%, BRKR is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
- In the last couple of years the Operating Margin of BRKR has declined.
- BRKR has a Gross Margin (48.00%) which is in line with its industry peers.
- In the last couple of years the Gross Margin of BRKR has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.99% | ||
| PM (TTM) | N/A | ||
| GM | 48% |
OM growth 3Y-13.3%
OM growth 5Y-4.84%
PM growth 3Y-33.57%
PM growth 5Y-18.8%
GM growth 3Y-0.46%
GM growth 5Y0.54%
2. Health
2.1 Basic Checks
- BRKR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- The number of shares outstanding for BRKR has been increased compared to 1 year ago.
- The number of shares outstanding for BRKR has been reduced compared to 5 years ago.
- The debt/assets ratio for BRKR is higher compared to a year ago.
2.2 Solvency
- An Altman-Z score of 2.57 indicates that BRKR is not a great score, but indicates only limited risk for bankruptcy at the moment.
- Looking at the Altman-Z score, with a value of 2.57, BRKR is in line with its industry, outperforming 56.14% of the companies in the same industry.
- A Debt/Equity ratio of 0.82 indicates that BRKR is somewhat dependend on debt financing.
- The Debt to Equity ratio of BRKR (0.82) is worse than 75.44% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.82 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.57 |
ROIC/WACC0.39
WACC10.2%
2.3 Liquidity
- BRKR has a Current Ratio of 1.85. This is a normal value and indicates that BRKR is financially healthy and should not expect problems in meeting its short term obligations.
- With a Current ratio value of 1.85, BRKR is not doing good in the industry: 61.40% of the companies in the same industry are doing better.
- A Quick Ratio of 0.89 indicates that BRKR may have some problems paying its short term obligations.
- With a Quick ratio value of 0.89, BRKR is not doing good in the industry: 84.21% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.85 | ||
| Quick Ratio | 0.89 |
3. Growth
3.1 Past
- The earnings per share for BRKR have decreased strongly by -18.37% in the last year.
- The Earnings Per Share has been growing by 8.95% on average over the past years. This is quite good.
- BRKR shows a small growth in Revenue. In the last year, the Revenue has grown by 6.10%.
- The Revenue has been growing by 10.19% on average over the past years. This is quite good.
EPS 1Y (TTM)-18.37%
EPS 3Y4.7%
EPS 5Y8.95%
EPS Q2Q%-25%
Revenue 1Y (TTM)6.1%
Revenue growth 3Y11.66%
Revenue growth 5Y10.19%
Sales Q2Q%-0.45%
3.2 Future
- The Earnings Per Share is expected to grow by 5.58% on average over the next years.
- The Revenue is expected to grow by 3.38% on average over the next years.
EPS Next Y-20.53%
EPS Next 2Y-4.9%
EPS Next 3Y1.14%
EPS Next 5Y5.58%
Revenue Next Year1.9%
Revenue Next 2Y1.7%
Revenue Next 3Y2.71%
Revenue Next 5Y3.38%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 25.44, the valuation of BRKR can be described as expensive.
- 82.46% of the companies in the same industry are more expensive than BRKR, based on the Price/Earnings ratio.
- When comparing the Price/Earnings ratio of BRKR to the average of the S&P500 Index (27.30), we can say BRKR is valued inline with the index average.
- BRKR is valuated rather expensively with a Price/Forward Earnings ratio of 23.34.
- 82.46% of the companies in the same industry are more expensive than BRKR, based on the Price/Forward Earnings ratio.
- Compared to an average S&P500 Price/Forward Earnings ratio of 24.04, BRKR is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.44 | ||
| Fwd PE | 23.34 |
4.2 Price Multiples
- BRKR's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. BRKR is cheaper than 84.21% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 18.02 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)2.84
EPS Next 2Y-4.9%
EPS Next 3Y1.14%
5. Dividend
5.1 Amount
- BRKR has a yearly dividend return of 0.38%, which is pretty low.
- Compared to an average industry Dividend Yield of 0.09, BRKR pays a better dividend. On top of this BRKR pays more dividend than 89.47% of the companies listed in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.92, BRKR's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.38% |
5.2 History
- The dividend of BRKR has a limited annual growth rate of 4.81%.
- BRKR has been paying a dividend for at least 10 years, so it has a reliable track record.
- BRKR has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)4.81%
Div Incr Years0
Div Non Decr Years8
5.3 Sustainability
- BRKR has negative earnings and hence a negative payout ratio. The dividend may be in danger.
- The dividend of BRKR is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP-96.62%
EPS Next 2Y-4.9%
EPS Next 3Y1.14%
50.88
-2.53 (-4.74%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)11-03 2025-11-03/bmo
Earnings (Next)02-11 2026-02-11/amc
Inst Owners90.2%
Inst Owner Change0.06%
Ins Owners26.95%
Ins Owner Change0.17%
Market Cap7.73B
Revenue(TTM)3.44B
Net Income(TTM)-23.70M
Analysts79.09
Price Target51.65 (1.51%)
Short Float %11.12%
Short Ratio4.76
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.38% |
Yearly Dividend0.2
Dividend Growth(5Y)4.81%
DP-96.62%
Div Incr Years0
Div Non Decr Years8
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.84%
Min EPS beat(2)-26.01%
Max EPS beat(2)31.69%
EPS beat(4)3
Avg EPS beat(4)3.35%
Min EPS beat(4)-26.01%
Max EPS beat(4)31.69%
EPS beat(8)5
Avg EPS beat(8)4.64%
EPS beat(12)9
Avg EPS beat(12)5.65%
EPS beat(16)11
Avg EPS beat(16)6.13%
Revenue beat(2)0
Avg Revenue beat(2)-2.12%
Min Revenue beat(2)-3.65%
Max Revenue beat(2)-0.6%
Revenue beat(4)1
Avg Revenue beat(4)-0.53%
Min Revenue beat(4)-3.65%
Max Revenue beat(4)2.76%
Revenue beat(8)2
Avg Revenue beat(8)-0.53%
Revenue beat(12)6
Avg Revenue beat(12)0.67%
Revenue beat(16)9
Avg Revenue beat(16)0.72%
PT rev (1m)8.84%
PT rev (3m)12.88%
EPS NQ rev (1m)-0.26%
EPS NQ rev (3m)-24.3%
EPS NY rev (1m)0.27%
EPS NY rev (3m)-4.48%
Revenue NQ rev (1m)-0.1%
Revenue NQ rev (3m)-3.88%
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)-0.77%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.44 | ||
| Fwd PE | 23.34 | ||
| P/S | 2.25 | ||
| P/FCF | N/A | ||
| P/OCF | 81.98 | ||
| P/B | 3.18 | ||
| P/tB | N/A | ||
| EV/EBITDA | 18.02 |
EPS(TTM)2
EY3.93%
EPS(NY)2.18
Fwd EY4.28%
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)0.62
OCFY1.22%
SpS22.63
BVpS16.01
TBVpS-0.24
PEG (NY)N/A
PEG (5Y)2.84
Graham Number26.84
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.37% | ||
| ROE | -0.97% | ||
| ROCE | 5.98% | ||
| ROIC | 4.01% | ||
| ROICexc | 4.25% | ||
| ROICexgc | 8.62% | ||
| OM | 8.99% | ||
| PM (TTM) | N/A | ||
| GM | 48% | ||
| FCFM | N/A |
ROA(3y)6.74%
ROA(5y)6.6%
ROE(3y)21.33%
ROE(5y)21.26%
ROIC(3y)9.3%
ROIC(5y)9.28%
ROICexc(3y)11.26%
ROICexc(5y)12.82%
ROICexgc(3y)18.89%
ROICexgc(5y)20.78%
ROCE(3y)13.86%
ROCE(5y)13.83%
ROICexgc growth 3Y-22.35%
ROICexgc growth 5Y-9.61%
ROICexc growth 3Y-31.42%
ROICexc growth 5Y-15.9%
OM growth 3Y-13.3%
OM growth 5Y-4.84%
PM growth 3Y-33.57%
PM growth 5Y-18.8%
GM growth 3Y-0.46%
GM growth 5Y0.54%
F-Score5
Asset Turnover0.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.82 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 3.79 | ||
| Cap/Depr | 48.77% | ||
| Cap/Sales | 3.05% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 17.99% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.85 | ||
| Quick Ratio | 0.89 | ||
| Altman-Z | 2.57 |
F-Score5
WACC10.2%
ROIC/WACC0.39
Cap/Depr(3y)100.42%
Cap/Depr(5y)105.08%
Cap/Sales(3y)4.05%
Cap/Sales(5y)4.17%
Profit Quality(3y)75.38%
Profit Quality(5y)88.75%
High Growth Momentum
Growth
EPS 1Y (TTM)-18.37%
EPS 3Y4.7%
EPS 5Y8.95%
EPS Q2Q%-25%
EPS Next Y-20.53%
EPS Next 2Y-4.9%
EPS Next 3Y1.14%
EPS Next 5Y5.58%
Revenue 1Y (TTM)6.1%
Revenue growth 3Y11.66%
Revenue growth 5Y10.19%
Sales Q2Q%-0.45%
Revenue Next Year1.9%
Revenue Next 2Y1.7%
Revenue Next 3Y2.71%
Revenue Next 5Y3.38%
EBIT growth 1Y-16.55%
EBIT growth 3Y-3.19%
EBIT growth 5Y4.86%
EBIT Next Year9.99%
EBIT Next 3Y11.38%
EBIT Next 5Y10.68%
FCF growth 1Y-105.14%
FCF growth 3Y-10.61%
FCF growth 5Y-0.63%
OCF growth 1Y-70.17%
OCF growth 3Y-3.81%
OCF growth 5Y3.32%
BRUKER CORP / BRKR FAQ
Can you provide the ChartMill fundamental rating for BRUKER CORP?
ChartMill assigns a fundamental rating of 4 / 10 to BRKR.
What is the valuation status for BRKR stock?
ChartMill assigns a valuation rating of 3 / 10 to BRUKER CORP (BRKR). This can be considered as Overvalued.
Can you provide the profitability details for BRUKER CORP?
BRUKER CORP (BRKR) has a profitability rating of 5 / 10.
Can you provide the PE and PB ratios for BRKR stock?
The Price/Earnings (PE) ratio for BRUKER CORP (BRKR) is 25.44 and the Price/Book (PB) ratio is 3.18.
What is the financial health of BRUKER CORP (BRKR) stock?
The financial health rating of BRUKER CORP (BRKR) is 2 / 10.